Hong Kong
2 Vaccines Approved for Use in Hong Kong
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
84 trials in 27 countries
Approval Source: reuters.com
Inactivated
5 in Clinical Trials in Hong Kong
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
84 trials in 27 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
64 trials in 31 countries
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
37 trials in 9 countries
DNA
The University of Hong Kong
SARS-CoV-2 DNA Vaccine
Replicating Viral Vector
The University of Hong Kong